Daily BriefsIndia

Daily Brief India: Escorts Kubota, Edelweiss Financial Services, Balaji Speciality Chemicals and more

In today’s briefing:

  • Escorts Kubota (ESCORTS IN) | Alarming Allegations by Dealers
  • Edelweiss: Credit Business Is Normalizing; Rest of the Businesses Are Scaling Up Well
  • Balaji Speciality Chemicals Pre-IPO Tearsheet

Escorts Kubota (ESCORTS IN) | Alarming Allegations by Dealers

By Pranav Bhavsar

  • Escorts Kubota (ESCORTS IN) ‘s domestic market share as of FY22 stood at 10.3 % vs 12% in FY20 against the aspiration of 15% for FY22. 
  • Our interactions with various dealers across key northern and eastern states suggest caution and structural inability to regain market share loss.
  • Post equity infusion, Kubota Corp (6326 JP) is probably in for more surprises than what it might have initially hoped for. 

Edelweiss: Credit Business Is Normalizing; Rest of the Businesses Are Scaling Up Well

By Ankit Agrawal, CFA

  • Edelweiss’ credit business is now normalizing with GNPA at 2.5% and NNPA at 1.8%. Credit costs came in negative as asset quality is improving and excess provisioning is being normalized. 
  • Rest of the businesses continue to scale up well. Edelweiss is among the fastest grower in the mutual fund and insurance businesses. Wealth Management business continues to do well.
  • At current valuation, Edelweiss is available cheap and as per our estimates, an investment in it has potential to more than quadruple by the end of FY25.

Balaji Speciality Chemicals Pre-IPO Tearsheet

By Ethan Aw

  • Balaji Speciality Chemicals (1742663D IN) is looking to raise about US$126m in its upcoming India IPO. The deal will be run by JM Financial and HDFC Bank. 
  • Balaji Speciality Chemicals (BSC) is the sole manufacturer in India of niche chemicals such as Ethylenediamine, Piperazine (Anhydrous), Diethylenetriamine, Amino Ethyl Ethanol Amines and Amino Ethyl Piperazine, according to CRISIL.
  • The chemicals it manufactures are import substitutes and are used in end-use industries such as speciality chemicals. Its customer base grew from 45 in FY20 to 182 in FY22.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars